Shamil Patel, MD
Ophthalmology · Glendale, AZNPI 1821298134
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $76,930 of the $116,223 with a category attached, or 66.2%. Nova Eye, Inc. accounts for 64.1% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $35,088, more than ten times the $1,690 reported in 2019. Among ophthalmology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 356 payments — averaging $326.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nova Eye, Inc.$75K
- Glaukos Corporation$29K
- Aerie Pharmaceuticals, Inc.$3K
- AbbVie$3K
- Alcon$2K
- Bausch & Lomb Americas Inc.$2K
- plus $4K from 23 others
Across 34 payments — averaging $10,030 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$341K
What the payments were for
- Consulting fees$76,93066%
- Speaking & faculty fees$9,7508%
- Travel & lodging$13,28911%
- Food & beverage$16,25414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nova Eye, Inc. | 16 | $74,502 |
| Glaukos Corporation | 62 | $28,632 |
| Aerie Pharmaceuticals, Inc. | 74 | $3,189 |
| AbbVie(2 entities) | 82 | $2,757 |
| Alcon | 43 | $1,872 |
| Bausch & Lomb Americas Inc. | 22 | $1,515 |
| Carl Zeiss Meditec, Inc. | 1 | $600 |
| NEW World Medical,inc. | 7 | $541 |
| Rxsight Inc | 5 | $422 |
| Novartis | 5 | $374 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $365 |
| Sun Pharmaceutical Industries Inc. | 5 | $226 |
| Eyevance Pharmaceuticals LLC | 1 | $171 |
| Ivantis, Inc | 3 | $160 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $150 |
| Ocular Therapeutix, Inc. | 1 | $150 |
| Genentech USA, Inc. | 1 | $81 |
| Carl Zeiss Meditec USA, Inc. | 1 | $74 |
| Heidelberg Engineering, Inc. | 1 | $68 |
| Sight Sciences, Inc. | 2 | $67 |
| Kala Pharmaceuticals, Inc. | 3 | $65 |
| Rayner Intraocular Lenses Limited | 2 | $63 |
| Tearlab Corp | 2 | $40 |
| Thea Pharma Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $30 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| Amgen | 1 | $21 |
| Akorn, Inc. | 1 | $15 |
| Akorn Operating Company LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iDose$13,243
- Travoprost Intraocular Implant - iDose$5,600
- Rhopressa$2,072
- Rocklatan$2,072
- VYZULTA$1,247
- iDoseTR$1,049
- iStent inject W$985
- RESTASIS$750
- ARTEVO 800$600
- XEN GLAUCOMA TREATMENT SYSTEM$423
- RXSIGHT CONTACT LENS$374
- RXSIGHT INJECTOR CARTRIDGE$374
- RXSIGHT INJECTOR HANDPIECE$374
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$374
- Kahook Dual Blade$300
- Clearpath$300
- Ahmed Glaucoma Valve$300
- Streamline$300
- Via360$300
- Clareon$269
How this compares
$116,223 in reported general payments places this provider in the 95th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 298 | $134,782 |
| RocklatanNetarsudil Mesylat/Latanoprost | 188 | $92,061 |
| VyzultaLatanoprostene Bunod | 123 | $61,033 |
| CombiganBrimonidine Tartrate/Timolol | 94 | $37,116 |
| RhopressaNetarsudil Mesylate | 84 | $35,368 |
| Alphagan PBrimonidine Tartrate | 83 | $28,768 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 78 | $26,997 |
| RestasisCyclosporine | 30 | $24,219 |
| Prednisolone Acetate | 417 | $18,134 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 115 | $17,918 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 101 | $17,091 |
| Brinzolamide | 87 | $14,661 |
| Travoprost | 100 | $13,982 |
| Brimonidine Tartrate | 316 | $12,784 |
| TafluprostTafluprost/Pf | 55 | $10,180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P, Restasis | $2,757 | $224,885505 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $3,189 | $127,430272 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $1,515 | $61,033123 claims |
| AlconSimbrinza | $1,872 | $26,99778 claims |
| Akorn, Inc.Zioptan | $15 | $4,72515 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $365 | $1,71912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 310 ophthalmology providers in Arizona.
Other ophthalmology in Glendale
- George ReissGlendale$73K
- Wendy HuangGlendale$73K
- Anne FloydGlendale$11K
- Warren HillMesa$1.1M
- Mark BarakatScottsdale$794K
- Anne ZakiSun City West$518K
- Pravin DugelPhoenix$176K
- Derek KunimotoMesa$138K
- Yuri McKeeMesa$100K
- Nishi ShahPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.